Allogene Therapeutics Inc (ALLO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -316,381 | -181,651 | -115,454 | -54,480 | -184,594 |
| Depreciation Amortization | 10,836 | 7,179 | 3,952 | 1,837 | 1,431 |
| Accounts payable and accrued liabilities | 615 | 1,681 | -503 | -1,044 | -985 |
| Other Working Capital | 53,922 | 18,930 | 11,712 | -3,163 | -6,878 |
| Other Operating Activity | 135,915 | 48,743 | 32,763 | 16,041 | 53,676 |
| Operating Cash Flow | $-115,093 | $-105,118 | $-67,530 | $-40,809 | $-137,350 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -65,958 | -48,554 | -28,307 | -12,253 | -50,791 |
| Purchase Of Investment | -1,037,591 | -855,433 | -642,181 | -123,015 | -257,703 |
| Sale Of Investment | 598,426 | 376,654 | 226,510 | 120,261 | 472,578 |
| Investing Cash Flow | $-505,123 | $-527,333 | $-443,978 | $-15,007 | $164,084 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 633,591 | 620,613 | 616,761 | 16,586 | 58,960 |
| Financing Cash Flow | $633,591 | $620,613 | $616,761 | $16,586 | $58,960 |
| Beginning Cash Position | 179,425 | 179,425 | 179,425 | 179,425 | 93,731 |
| End Cash Position | 192,800 | 167,587 | 284,678 | 140,195 | 179,425 |
| Net Cash Flow | $13,375 | $-11,838 | $105,253 | $-39,230 | $85,694 |
| Free Cash Flow | |||||
| Operating Cash Flow | -115,093 | -105,118 | -67,530 | -40,809 | -137,350 |
| Capital Expenditure | -65,958 | -48,554 | -28,307 | -12,253 | -50,791 |
| Free Cash Flow | -181,051 | -153,672 | -95,837 | -53,062 | -188,141 |